Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples